Evidence map›Paper›PMID 25677579›Full record

ArticleHead & neck2016

Novel method of cell line establishment utilizing fluorescence-activated cell sorting resulting in 6 new head and neck squamous cell carcinoma lines.

John Henry Owen, Martin P Graham, Steven B Chinn, Owen F Darr, Douglas B Chepeha, Gregory T Wolf, Carol R Bradford, Thomas E Carey, Mark E P Prince

Abstract read
In one paragraph

Article in Head & neck, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Impact of dietary vitamin D on initiation and progression of oral cancer.The Journal of steroid biochemistry and molecular biology · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Trends in Surgical Research in Head and Neck Cancer.Current treatment options in oncology · 2017
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

John Henry OwenDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Martin P GrahamDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Steven B ChinnDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Owen F DarrDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Douglas B ChepehaDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Gregory T WolfDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Carol R BradfordDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Thomas E CareyDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Mark E P PrinceDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Therapeutic Potential and Mechanism of Action of Potent Small Molecule InhibitorsP50CA097248 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WOLF, GREGORY T · 2002 to 2013
$25.3M
Scientific Synergy CoreP30DC005188 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DOLAN, DAVID FRANCIS · 2002 to 2016
$10.3M
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal CancerR01DE019126 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CAREY, THOMAS E. · 2009 to 2012
$1.4M
NCI NIH HHS P30 CA046592NCI NIH HHS P50 CA097248NIDCD NIH HHS P30 DC005188NIDCR NIH HHS R01 DE019126
6 · The paper itself

Abstract

backgroundThe purpose of this study was to present the establishment of new cell lines, which is important to cancer research.

methodsSix new head and neck squamous cell carcinoma cell lines were established using a novel fluorescence-activated cell sorting (FACS) method in order to overcome the barrier of fibroblast overgrowth and the susceptibility of primary tumors to fail in vitro.

resultsAntibodies chosen for specific targeting of epithelial cells and fibroblasts successfully separated cells for line establishment in 6 of 12 attempts, providing an alternative method of establishing head and neck squamous cell carcinoma cell lines. Each attempt at cell line establishment resulted in an epithelial carcinoma population, which was genotyped and catalogued as a unique cell line, and a corresponding fibroblast population.

conclusionThe selection of antibody markers could be optimized to aid in the establishment of any cancer cell line derived from any tumor tissue; this method is not limited to head and neck cancer. © 2015 Wiley Periodicals, Inc. Head Neck 38: E459-E467, 2016.

Indexed as

Cell Line, TumorFlow CytometryAntibodiesCarcinoma, Squamous CellCell Culture TechniquesCell SeparationEpithelial CellsFibroblastsHead and Neck NeoplasmsHumansAntibodiescell linefibroblastsflow cytometrysquamous cell carcinoma

Identifiers

PMID25677579
PMCPMC4530106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.